A critical discovery in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in various types of cancer, resulting https://prbookmarkingwebsites.com/story29914020/nanobodies-revive-p53-new-promising-approach-for-tumor-management